State Street’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.29M Buy
1,239,663
+872,353
+237% +$4.42M ﹤0.01% 2837
2025
Q1
$1.11M Buy
367,310
+66,800
+22% +$202K ﹤0.01% 3405
2024
Q4
$1.09M Buy
300,510
+132,202
+79% +$479K ﹤0.01% 3474
2024
Q3
$296K Hold
168,308
﹤0.01% 3721
2024
Q2
$263K Buy
168,308
+1,500
+0.9% +$2.34K ﹤0.01% 3741
2024
Q1
$325K Hold
166,808
﹤0.01% 3758
2023
Q4
$235K Hold
166,808
﹤0.01% 3864
2023
Q3
$264K Hold
166,808
﹤0.01% 3855
2023
Q2
$360K Buy
166,808
+83,900
+101% +$181K ﹤0.01% 3793
2023
Q1
$174K Hold
82,908
﹤0.01% 4124
2022
Q4
$182K Hold
82,908
﹤0.01% 4144
2022
Q3
$249K Hold
82,908
﹤0.01% 4040
2022
Q2
$235K Hold
82,908
﹤0.01% 4126
2022
Q1
$444K Buy
82,908
+26,909
+48% +$144K ﹤0.01% 4101
2021
Q4
$418K Hold
55,999
﹤0.01% 4087
2021
Q3
$508K Buy
55,999
+800
+1% +$7.26K ﹤0.01% 3973
2021
Q2
$269K Buy
+55,199
New +$269K ﹤0.01% 4103
2016
Q2
Sell
-4,878
Closed -$270K 3769
2016
Q1
$270K Buy
4,878
+1,664
+52% +$92.1K ﹤0.01% 3457
2015
Q4
$444K Sell
3,214
-7
-0.2% -$967 ﹤0.01% 3355
2015
Q3
$461K Buy
3,221
+558
+21% +$79.9K ﹤0.01% 3351
2015
Q2
$691K Buy
+2,663
New +$691K ﹤0.01% 3313